"Pharmaceutical Headlines" this month the European Union CHMP recommended five new drugs on the market

(2020/11/16) CDK4/6 inhibitors vying for early breast cancer: why Abesili came to the fore; how much the new Biosecurity Act affects the biopharmaceutical industry; how much the story of prescription drug online sales bans medical e-commerce providers can tell; and how much a village health room infusion is fined thousands of dollars. (Click on the title, you can get the original text) "Pharmaceutical 1st time" this month the EU CHMP recommended 5 new drugs on the market! Including Roche Xofluza, Samsung Onbevzi 14, the European Medicines Agency (EMA) Human Medicines Commission (CHMP) at its monthly meeting recommended the approval of five drugs, one of which was approved after a re-examination, and the approval of six drugs was extended.
, CHMP issued a non-recommendation after a review, and three companies withdrew their marketing applications.
headlines: Agios withdraws Tibsovo application
the Medical Rubik's Cube CDK4/6 inhibitors for early breast cancer: Why did Abesili come to the fore? Recently, Pfizer announced another failure in the clinical study of early breast cancer, and the Phase III PENELOPE-B study also failed to reach the main endpoint of the immerizing disease lifetime (IDFS).
so many, it's thought-provoking - why did the MonarchE and PALAS study come to a different end? What's so special about Abesili? Headline bacteria: Abesili's maximum trial phase is in Phase II.
the impact of the new Biosecurity Act on the biopharmaceutical industry? The introduction of biosafe law will help to solve the problems in the field of biosafe management in China from the legal system level and ensure the healthy development of biotechnology.
As an industry closely related to biosecurity, biopharmaceutical research and development, production, circulation and other links will be included in the scope of biosecurity law, biosecurity law will bring new global impact on the standardized development of biopharmaceutical industry.
: The introduction of biosecurity laws is both a challenge and an opportunity for biopharmaceutical companies.
can the story of the prescription drug online sale be told? Prescription drug online sales ban is only a limited benefit to pharmaceutical e-commerce, in the long run, after outpatient co-ordination, medical institutions rather than outside the hospital will continue to be the main scenario of prescription sales, outside the hospital can only be a narrow market under the limited supplement.
: The ban on online sales of prescription drugs is only a limited profit for pharmaceutical e-commerce.
"Primary Physicians Commune" a village health room infusion was fined thousands of yuan these things must bear in mind recently, Tianjin Jinnan District Health And Health Commission issued the "November 2020 second batch of Jinnan District Health Administrative Punishment Case Public Information", which announced a Case of Tianjin Jinnan District Geyu Town Health Hospital Liuzhuang Village Health Institute without approval to use antimicrobial drugs to carry out intravenous infusion activities.
: Village health room can not easily carry out infusion activities!